Bai Y, Zhang Y, Zhang J, Mu Q, Zhang W, Butch ER, Snyder SE, Yan B. Repeated carbon nanotube administrations in male mice cause reversible testis damage without affecting fertility. Nature Nanotechnology (in press), 2010.
Loveless VS, Surdock CP, Bhattacharjee H. Evaluation of Zeta-Potential and Particle Size of Technetium 99mTc-Sulfur Colloid Subsequent to the Addition of Lidocaine and Sodium Bicarbonate. Journal of Nuclear Medicine Technology 38(1): 49-52, 2010.
Sorkin LS, Otto M, Baldwin WM 3rd, Vail E, Gillies SD, Handgretinger R, Barfield RC, Ming Yu H, Yu AL. Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia. Pain 149(1): 135-42, 2010.
Vāvere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography. Cancer Research 69: 4510-4516, 2009.
Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. Nuclear Medicine & Biology 7(1): 3-8, 2009.
Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands. Nuclear Medicine & Biology 35(5): 549-59, 2008.
Gomez V, Gispert JD, Amador V, Llop J. New method for routine production of L-[methyl-11C]methionine: in loop synthesis. Journal of Labelled Compounds & Radiopharmaceuticals 51(1): 83-86, 2008.
Bonnitcha PD, Vāvere AL, Lewis JS, Dilworth JR. In Vitro and In Vivo Evaluation of Bifunctional Bisthiosemicarbasone 64Cu-Complexes for the Positron Emission Tomography Imaging of Hypoxia. Journal of Medicinal Chemistry 51: 2985-2991, 2008.
Vāvere AL, Lewis JS. Examining the Relationship Between Cu-ATSM Hypoxia Selectivity and Fatty Acid Synthase Expression in Human Prostate Cancer Cell Lines. Nuclear Medicine and Biology 35: 273-279, 2008.
Vāvere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer. Journal of Nuclear Medicine 49(2): 327-334, 2008.
Kilbourn MR, Ma B, Butch ER, Quesada C, Sherman PS. Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor. Nuclear Medicine & Biology 34(5): 479-82, 2007.
Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Vāvere AL, Lewis JS. Ga-68 labeled DOTA-Rhenium Cyclized a-MSH Analog for Imaging of Malignant Melanoma. Nuclear Medicine & Biology 34: 945-953, 2007.
Vāvere AL, Lewis JS. Cu-ATSM for the PET Imaging of Hypoxia. Dalton Transactions (43): 4893-4902, 2007.
Otto M, Chen X, Martin WJ, Leung W, Knowles J, Holladay M, Houston J, Handgretinger R, Barfield RC. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. Stem Cells 25(2): 537-42, 2007.
Barfield R, Chen X, Otto M, Handgretinger R. Beyond the FACS. Stem Cells 25(11): 2972, 2007.
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrulcholinesterase activity in Alzheimer's disease. Annals of Neurology 60(6): 746, 2006.
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology 59(1):13-20, 2006.
Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers. Bioorganic & Medicinal Chemistry 13(3): 869-75, 2005.
Vāvere AL, Welch MJ. Preparation, Biodistribution and MicroPET Imaging of Titanium-45-Transferrin. Journal of Nuclear Medicine 46(4): 683-690, 2005.
Vāvere AL, Laforest R, Welch MJ. Production, Preparation and MicroPET Imaging of Titanium-45. Nuclear Medicine & Biology 32(2): 117-122, 2005.
Otto M, Barfield RC, Martin WJ, Iyengar R, Leung W, Leimig T, Chaleff S, Gillies SD, Handgretinger R. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma. Clinical Cancer Research 11(23): 8486-91, 2005.
Otto M, Barfield RC, Iyengar R, Gatewood J, Müller I, Holladay MS, Houston J, Leung W, Handgretinger R. Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. Journal of Immunotherapy 28(1): 73-8, 2005.
Chen X, Barfield R, Benaim E, Leung W, Knowles J, Lawrence D, Otto M, Shurtleff SA, Neale GA, Behm FG, Turner V, Handgretinger R. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogenic hematopoietic stem cell transplantation in pediatric patients. Blood 105(2): 886-93, 2005.